These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 6894381)

  • 41. [Changes of acid phosphatase in the gastric mucosa during ulcerogenesis].
    Amirov NSh; Trubitsyna IE
    Biull Eksp Biol Med; 1982 Sep; 94(9):55-7. PubMed ID: 6756505
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cysteamine, the most potent ulcerogenic drug known so far, powerfully activates carbonic anhydrase I, II and IV. In vitro and in vivo studies.
    Puscas I; Coltau M; Maghiar A; Domuta G
    Exp Toxicol Pathol; 2000 Oct; 52(5):431-5. PubMed ID: 11089894
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Healing-promoting action of the new histamine H2-receptor antagonist N-ethyl-N'-[3-[3-(piperidinomethyl)phenoxy]propyl]urea with dual action on chronic gastric and duodenal ulcers induced by acetic acid in rats.
    Sekiguchi H; Hamada K; Aijima H; Taga F; Uchida H; Nishino K
    Arzneimittelforschung; 1993 Feb; 43(2):139-43. PubMed ID: 8096134
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Inhibition of gastric acid secretion by selective and nonselective anticholinergics.
    Feldman M
    Gastroenterology; 1984 Feb; 86(2):361-6. PubMed ID: 6360787
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [The effect of pirenzepine (LS 519) on basal and pentagastrin-stimulated gastric acid secretion in normal persons].
    Galmiche JP; Lerebours E; Colin R
    Med Chir Dig; 1980; 9(4):331-4. PubMed ID: 6894012
    [No Abstract]   [Full Text] [Related]  

  • 46. Effects of prolonged treatment of pirenzepine 2HCl on gastric secretion and plasma gastrin levels in rats.
    Okabe S; Tabata K; Kawakami M
    Arzneimittelforschung; 1982; 32(6):664-8. PubMed ID: 6896823
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Effect of pirenzepine and atropine on the transmural gastric mucosal potential difference (author's transl)].
    von Kleist D; Staud R; Stopik D; Hampel HE
    Dtsch Z Verdau Stoffwechselkr; 1980; 40(3-4):110-4. PubMed ID: 6893819
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Pirenzepine selectively inhibits gastric acid secretion: a comparative pharmacological study between pirenzepine and seven other antiacetylcholine drugs.
    Heathcote BV; Parry M
    Scand J Gastroenterol Suppl; 1980; 66():15-26. PubMed ID: 6113681
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Interrelationships of histamine, erythrocytic carbonic anhydrase and gastric acid secretion].
    Puşcaş I; Tudoran L; Contrasiu P; Surany P; Domuţa M
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1979; 31(6):555-8. PubMed ID: 44759
    [No Abstract]   [Full Text] [Related]  

  • 50. Pirenzepine and gastroduodenal ulcers.
    Cameron AD
    N Z Med J; 1985 Jan; 98(771):27. PubMed ID: 3855517
    [No Abstract]   [Full Text] [Related]  

  • 51. [Acid proteinases in the gastric mucosa in stomach diseases].
    Kohout J; Korbová L; Cízková J; Kucerová Z; Marek J; Kasafírek E
    Cas Lek Cesk; 1985 Jan; 124(2):53-6. PubMed ID: 3884156
    [No Abstract]   [Full Text] [Related]  

  • 52. [Effect of long-term H2-blocker treatment on carbonic anhydrase in rat gastroduodenal mucosa].
    Miyake K
    Nihon Ika Daigaku Zasshi; 1992 Apr; 59(2):129-35. PubMed ID: 1577915
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Carbonic anhydrase inhibitors: DNA cloning and inhibition studies of the alpha-carbonic anhydrase from Helicobacter pylori, a new target for developing sulfonamide and sulfamate gastric drugs.
    Nishimori I; Minakuchi T; Morimoto K; Sano S; Onishi S; Takeuchi H; Vullo D; Scozzafava A; Supuran CT
    J Med Chem; 2006 Mar; 49(6):2117-26. PubMed ID: 16539401
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Specific IgE in the gastric and duodenal mucosa. An epiphenomenon or pathogenetic mechanism of some forms of "peptic" ulcer?].
    De Lazzari F; Venturi C; Fregona I; Galliani EA; Bortolami M; Violato D; Floreani AR; Plebani M; Naccarato R
    Minerva Gastroenterol Dietol; 1994 Mar; 40(1):1-9. PubMed ID: 8204699
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The effect of pirenzepine on basal, pentagastrin- and insulin-stimulated gastric acid secretion in patients with peptic ulcer disease.
    Jaup BH; Stockbrügger R; Dotevall G
    Scand J Gastroenterol; 1979; 14(5):621-4. PubMed ID: 493866
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The effect of pirenzepine and L-hyoscyamine on gastric emptying and salivary secretion in healthy volunteers.
    Jaup BH; Dotevall G
    Scand J Gastroenterol; 1981; 16(6):769-73. PubMed ID: 6119766
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Lysozyme concentration in the gastric juice in peptic ulcer].
    Lobanova ND; Rudyk BI
    Antibiotiki; 1980 Jan; 25(1):48-51. PubMed ID: 7356301
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Prostaglandins with vasodilating effects inhibit carbonic anhydrase while vasoconstrictive prostaglandins and leukotriens B4 and C4 increase CA activity.
    Puscas I; Coltau M
    Int J Clin Pharmacol Ther; 1995 Mar; 33(3):176-81. PubMed ID: 7599917
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Serum zinc level : a possible index in the pathogenesis of peptic ulcer syndrome.
    Bandyopadhyay B; Banerjee P; Bhattacharya B; Bandyopadhyay SK
    Biochem Mol Biol Int; 1995 Aug; 36(5):965-72. PubMed ID: 7581013
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effect of two doses of pirenzepine on histamine-stimulated gastric acid secretion in man.
    Eugenides N; Stockbrügger RW; Hobsley M; Cotton PB
    Scand J Gastroenterol Suppl; 1982; 72():125-9. PubMed ID: 6957980
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.